Acrivon Therapeutics, Inc. Made Headway
Tue, Jan 06, 2026 at 07:25 PM
Acrivon Therapeutics, Inc. (ACRV:NASDAQ) jumped higher at $3.01, a gain of 31.4%. On Tue, Jan 06, 2026, ACRV:NASDAQ hit a New 2-Week High of $3.01. The stock appeared on our News Catalysts scanner on Tue, Jan 06, 2026 at 08:33 AM in the 'BIOTECH' category. From Tue, Dec 23, 2025, the stock recorded 62.50% Up Days and 55.56% Green Days
About Acrivon Therapeutics, Inc. (ACRV:NASDAQ)
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific...
Top 10 Gainers:
- Alumis Inc. (ALMS:NASDAQ), 95.31%
- Sky Quarry Inc. (SKYQ:NASDAQ), 88.84%
- Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 70.83%
- Envirotech Vehicles, Inc. (EVTV:NASDAQ), 49.01%
- Murano Global Investments Plc (MRNO:NASDAQ), 41.47%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 41.3%
- Aeva Technologies, Inc. (AEVA:NASDAQ), 34.38%
- Aeva Technologies, Inc. (AEVA:NYSE), 34.38%
- Acrivon Therapeutics, Inc. (ACRV:NASDAQ), 31.44%
- Terrestrial Energy Inc Com (IMSR:NASDAQ), 30.33%